Malayan, Lorna M.
HRN: 28-52-83 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2026
CEFTAZIDIME 1GM (VIAL)
02/11/2026
02/18/2026
IV
2g
Q24
HAP
Checking Initial Appropriateness
02/11/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
02/11/2026
02/18/2026
IV
750mg
LD
HAP
Checking Initial Appropriateness
02/11/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
02/11/2026
02/18/2026
IV
500mg
Q48
HAP
Checking Initial Appropriateness
02/13/2026
MUPIROCIN 2%, 15G (TUBE)
02/13/2026
02/19/2026
TOPICAL
Apply Thinly
BID
Sacral Ulcer
Checking Initial Appropriateness